Amy Herr's most recent trade in Bio-Techne Corp was a trade of 1,976 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 14, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Bio-Techne Corp | Amy Herr | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2025 | 1,976 | 1,280 | - | - | Stock Option (Right to Buy) | |
Bio-Techne Corp | Amy Herr | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 44.33 per share. | 14 Feb 2025 | 1,976 | 3,836 (0%) | 0% | 44.3 | 87,596 | Common Stock |
Bio-Techne Corp | Amy Herr | Director | Sale of securities on an exchange or to another person at price $ 65.96 per share. | 14 Feb 2025 | 1,860 | 1,976 (0%) | 0% | 66.0 | 122,691 | Common Stock |
Bio-Techne Corp | Amy Herr | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 2,415 | 2,415 | - | - | Stock Option (Right to Buy) | |
Bio-Techne Corp | Amy Herr | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 1,040 | 1,040 (0%) | 0% | 0 | Common Stock | |
Bio-Techne Corp | Amy Herr | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 344 | 344 | - | - | Stock Option (Right to Buy) | |
Bio-Techne Corp | Amy Herr | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 115 | 115 | - | - | Restricted Stock Units |